UK guidelines for the management of cutaneous melanoma

被引:156
作者
Roberts, DLL
Anstey, AV
Barlow, RJ
Cox, NH
Bishop, JAN
Corrie, PG
Evans, J
Gore, ME
Hall, PN
Kirkham, N
机构
[1] St James Univ Hosp, ICRF, Clin Ctr Leeds, Genet Epidemiol Div, Leeds LS9 7TF, W Yorkshire, England
[2] Singleton Hosp, Swansea SA2 8QA, W Glam, Wales
[3] Royal Gwent Hosp, Newport NP9 2UB, Gwent, Wales
[4] St Thomas Hosp, St Johns Inst Dermatol, London SE1 7EH, England
[5] Cumberland Infirm, Dept Dermatol, Carlisle CA2 7HY, England
[6] Addenbrookes Hosp, Cambridge CB2 2QQ, England
[7] Nuffield Hosp, Plymouth, Devon, England
[8] Royal Marsden Hosp, London SW3 6JJ, England
[9] Royal Sussex Cty Hosp, Dept Histopathol, Brighton BN2 5BE, E Sussex, England
关键词
D O I
10.1046/j.1365-2133.2001.04614.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
These guidelines for management of cutaneous melanoma present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation. To reflect the collaborative process for the U.K., they a-re subject to dual publication in the British Journal of Dermatology and the British Journal of Plastic Surgery.(1)
引用
收藏
页码:7 / 17
页数:11
相关论文
共 62 条
[1]  
ARMSTRONG B, 1993, P ENV UV RAD HLTH EF, P106
[2]   EPIDEMIOLOGY OF MALIGNANT-MELANOMA - INTERMITTENT OR TOTAL ACCUMULATED EXPOSURE TO THE SUN [J].
ARMSTRONG, BK .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1988, 14 (08) :835-849
[3]  
Austin JR, 1996, HEAD NECK-J SCI SPEC, V18, P107, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<107::AID-HED1>3.3.CO
[4]  
2-P
[5]   EFFICACY OF 2-CM SURGICAL MARGINS FOR INTERMEDIATE-THICKNESS MELANOMAS (1 TO 4 MM) - RESULTS OF A MULTIINSTITUTIONAL RANDOMIZED SURGICAL TRIAL [J].
BALCH, CM ;
URIST, MM ;
KARAKOUSIS, CP ;
SMITH, TJ ;
TEMPLE, WJ ;
DRZEWIECKI, K ;
JEWELL, WR ;
BARTOLUCCI, AA ;
MIHM, MC ;
BARNHILL, R ;
WANEBO, HJ .
ANNALS OF SURGERY, 1993, 218 (03) :262-269
[6]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[7]   COST-EFFECTIVENESS OF SURVEILLANCE OF STAGE-I MELANOMA - A RETROSPECTIVE APPRAISAL BASED ON A 10-YEAR EXPERIENCE IN A DERMATOLOGY DEPARTMENT IN FRANCE [J].
BASSERES, N ;
GROB, JJ ;
RICHARD, MA ;
THIRION, X ;
ZAROUR, H ;
NOE, C ;
COLLETVILETTE, AM ;
LOTA, I ;
BONERANDI, JJ .
DERMATOLOGY, 1995, 191 (03) :199-203
[8]   Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: A case-control study [J].
Bataille, V ;
Bishop, JAN ;
Sasieni, P ;
Swerdlow, AJ ;
Pinney, E ;
Griffiths, K ;
Cuzickz, J .
BRITISH JOURNAL OF CANCER, 1996, 73 (12) :1605-1611
[9]  
BOHLERSOMMEREGGER K, 1992, PLAST RECONSTR SURG, V90, P436
[10]  
CALMAN K, 1995, REPORT ADVISORY GROU